Last update 31 Jan 2026

Bemfivastatin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
PPD-10558, RBX 10558, RBX-10558
Target
HMGCR
Action
inhibitors
Mechanism
HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors)
Therapeutic Areas
Nervous System DiseasesCongenital DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication-
Inactive Indication
MyalgiaPrimary hypercholesterolemiaSAM syndrome
Originator Organization
ActavisActavis
Active Organization-
Inactive Organization
Furiex Pharmaceuticals, Inc.Furiex Pharmaceuticals, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC34H37FN2O6
InChIKeyPMFRPLBQEYHUMG-VSGBNLITSA-N
CAS Registry805241-79-6

Related

1
Clinical Trials associated with Bemfivastatin
NCT01279590
/ CompletedPhase 2
A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia
100 Clinical Results associated with Bemfivastatin
Login to view more data
100 Translational Medicine associated with Bemfivastatin
Login to view more data
100 Patents (Medical) associated with Bemfivastatin
Login to view more data
100 Deals associated with Bemfivastatin
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MyalgiaPhase 2
United States
Furiex Pharmaceuticals, Inc.Furiex Pharmaceuticals, Inc.
01 Mar 2011
Primary hypercholesterolemiaPhase 2
United States
Furiex Pharmaceuticals, Inc.Furiex Pharmaceuticals, Inc.
01 Mar 2011
SAM syndromePhase 2
United States
Furiex Pharmaceuticals, Inc.Furiex Pharmaceuticals, Inc.
01 Mar 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free